122
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Successful embolization of iatrogenic ruptured coronary artery using Onyx: A new technique

&
Pages 123-126 | Received 24 May 2014, Accepted 10 Jul 2014, Published online: 11 Aug 2014

References

  • Gunning MG, Williams IL, Jewitt DE, Shah AM, Wainwright RJ, Thomas MR. Coronary artery perforation during percutaneous intervention: Incidence and outcome. Heart 2002; 88:495–8.
  • Gaxiola E, Browne KF. Coronary artery perforation repair using microcoil embolization. Cathet Cardiovasc Diagn. 1998;43: 474–6.
  • Katsanos K, Patel S, Dourado R, Sabharwal T. Lifesaving embolization of coronary artery perforation. Cardiovasc Intervent Radiol. 2009;32:1071–4.
  • Eshadri N, Whitlow PL, Acharga N, Honghtaling P, Blockstone EM, Ellis SG. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation 2002;106:2346–50.
  • Aslam MS, Messersmith RN, Gilbert J, Lakier JB. Successful management of coronary artery perforation with helical platinum microcoil embolization. Cathet Cardiovasc Intervent. 2000; 51:320–2.
  • Dixon SR, Webster MWI, Ormiston JA, Wattie WJ, Hammett CJK. Gelfoam embolization of a distal coronary artery guidewire perforation. Cathet Cardiovasc Intervent. 2000;49:214–7.
  • Yoo B, Yoon J, Lee SH, Kim JY, Lee HH, Ko JY, et al. Guidewire-induced coronary artery perforation treated with transcatheter injection of polyvinyl alcohol foam. Cathet Cardiovasc Intervent. 2001;52:231–4.
  • Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H. A new liquid material for embolization of arteriovenous malformations. Am J Neuroradiol. 1990;11:163–8.
  • Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008;50:589–97.
  • Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: Pharmacological, cellular, and molecular aspects. Biochem Pharmacol. 2003;65:1035–41.
  • Swanson BN. Medical use of dimethyl sulfoxide (DMSO). Rev Clin Basic Pharm. 1985;5:1–33.
  • Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 1994;90:2725–30.
  • Fukutomi T, Suzuki T, Popma J, Hosokawa H, Yokoya K, Inada T, et al. Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J. 2002;66:349–56.
  • Iakovou I, Colombo A. Management of right coronary artery perforation during percutaneous coronary intervention with polyvinyl alcohol foam embolization particles. J Invasive Cardiol. 2004;16:727–8.
  • Murayama Y, Vinuela F, Ulhoa A, Akida Y, Duckmiler GR, Gobin YP. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine retemirabile. Neurosurgery 1998;43:1164–75.
  • Asouhidou I, Katsaridis V, Meng L, Zilianaki D, Vaidis G, Ioannou P. Desaturation during Onyx embolization. Br J Anaesth. 2010;105:385–6.
  • Pamuk AG, Saatci I, Cekirge HS, Aypar U. A contribution to the controversy over dimethyl sulfoxide toxicity: Anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms. Neuroradiology 2005;47:380–6.
  • Lv X, Jiang C, Zhang J, Li Y, Wu Z. Complications related to percutaneous transarterial embolization of intracranial dural arteriovenous fistulas in 40 patients. Am J Neuroradiol 2009; 30:462–8.
  • Murugesan C, Saravanan S, Rajkumar J, Prasad J, Banakal S, Muralidhar K. Severe pulmonary oedema following therapeutic embolization with Onyx for cerebral arteriovenous malformation. Neuroradiology 2008;50:439–42.
  • Tawil I, Carlson AP, Taylor CL. Acute respiratory distress syndrome after Onyx embolization of arteriovenous malformation. Crit Care Res Pract. 2011;2011:918185.
  • Panagiotopoulos V, Möller-Hartmann W, Asgari S, Sandalcioglu IE, Forsting M, Wanke I. Onyx embolization as a first line treatment for intracranial dural arteriovenous fistulas with cortical venous reflux. Rofo 2009;181:129–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.